mumms Software Announces New Clinical Workflow in Hummingbird EMR – SmartChart - Bringing Monumental Change to the Hospice EMR Industry

Kicking off the new year, mumms Software unveiled the new dashboard and workflow for hospice clinicians in its groundbreaking hospice EMR, Hummingbird. The highly anticipated new workflow will put patient data at the forefront of care improving the lives of hospice clinicians and their patients. Among the tools previewed during the demo was the new patient manifest, which replaces Hummingbird’s existing Chart App [PR.com]

Home Care Insurance Options in Georgia and Colorado Explored by Long-Term Care Insurance Association

Two new videos explore home care insurance options available for older Americans residing in Georgia and Colorado. The videos were produced by the American Association for Long-Term Care Insurance (AALTCI). "When you live a long life, the chances you'll need care become highly likely," explains Jesse Slome, director of the long-term care insurance organization. "When that happens, people want to remain in [PR.com]

Mark Cherchio Freehold Home Under Contract

Mark Cherchio was proud to announce the newly renovated home on Tree Top Circle in Freehold, New Jersey is under contract. Cherchio noted the home was owned by the bank and was in total disarray. Cherchio noted that the home was completely renovated, from new windows, roofing expansive Kitchen and complete bathrooms. The home was offered at a price point for most first time home buyers. Cherchio noted the home was [PR.com]

Dingtone’s Phone Calls Surge a Record 66% in 2020 as Coronavirus Emphasizes Importance of Connection

The year 2020 is almost over and will remain in the memory of people all over the world. People refer to 2020 as the year when everything changed. At this time of year, Dingtone, the popular VoIP service provider, released its annual summary for 2020 and took a look back at this different year. [PR.com]

Cisdem Duplicate Finder 5.6.0 Adds Support for Apple Silicon and Optimizes UI

Cisdem Duplicate Finder 5.6.0 adds support for Apple Silicon, fixes issues, optimizes interface and improves performance. [PR.com]

Robots with rhythm: Boston Dynamics' dancing androids a hit

These robots have rhythm.

source https://techxplore.com/news/2020-12-robots-rhythm-boston-dynamics-androids.html

Well-preserved Ice Age woolly rhino found in Siberia

A well-preserved Ice Age woolly rhino with many of its internal organs still intact has been recovered from permafrost in Russia's extreme north.

source https://phys.org/news/2020-12-well-preserved-ice-age-woolly-rhino.html

Facebook to close Irish units at center of tax dispute

Facebook confirmed Wednesday it was closing its Irish subsidiaries at the center of a dispute on profit shifting to avoid taxes in the United States.

source https://techxplore.com/news/2020-12-facebook-irish-center-tax-dispute.html

Amazon to buy hit podcast producer Wondery

Amazon said Wednesday it signed a deal to acquire the hit podcast production firm Wondery, in a move which boosts the US tech giant's efforts to round out its offerings from its music platform.

source https://techxplore.com/news/2020-12-amazon-podcast-wondery.html

Indonesia in $9.8 bln electric vehicle battery deal with Korea's LG

Indonesia said Wednesday it had signed a $9.8 billion electric vehicle battery deal with South Korea's LG as it moves to become a global production hub for the green technology.

source https://techxplore.com/news/2020-12-indonesia-bln-electric-vehicle-battery.html

Eastern Caribbean issues rare alerts for rumbling volcanoes

Volcanoes that have been quiet for decades are rumbling to life in the eastern Caribbean, prompting officials to issue alerts in Martinique and St. Vincent and the Grenadines as scientists rush in to study activity they say hasn't been observed in years.

source https://phys.org/news/2020-12-eastern-caribbean-issues-rare-rumbling.html

US expects to approve UK-backed AstraZeneca-Oxford vaccine in April

The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.

Canada to require negative Covid-19 test for entry

Canada will require travellers to obtain a negative Covid-19 test before being allowed into the country, the government announced Wednesday.

AstraZeneca vaccine approval unlikely in January: EU

The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).

US hits record daily Covid-19 deaths as world looks to vaccines in 2021

The US logged its highest ever daily death toll from the coronavirus Wednesday as the world prepares to turn the page on a grim year defined by the pandemic, with much of the globe united in one hope for 2021: that a slew of new vaccines will stamp out COVID-19.

Germany set for longer lockdown as death figures spike

German officials made clear Wednesday that they won't be able to relax lockdown restrictions in early January as the country recorded more than 1,000 deaths in one day for the first time.

China's first vaccine hustled to market as race to inoculate 1.3bn speeds up

China has granted "conditional" market approval to a Sinopharm vaccine with a reported 79 percent efficacy rate against COVID-19, health authorities said Thursday, a major stride towards inoculating the world's largest population.

Brain damage of patients with Covid-19

In an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease. In addition, they saw no signs of SARS-CoV-2 in the tissue samples, suggesting the damage was not caused by a direct viral attack on the brain. The results were published as a correspondence in the New England Journal of Medicine.

Moving due to unaffordable housing may jeopardize healthcare

People who move due to unaffordable housing are at increased risk of failing to receive the medical care they need, according to a new study from Cedars-Sinai and the University of California, Los Angeles. The study, published online in the Journal of General Internal Medicine, concludes that the result could be long-term health problems.

Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy

A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection. Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed symptomatic COVID-19 compared to 185 participants who received the placebo, demonstrating 94.1 percent efficacy in preventing symptomatic COVID-19. Cases of severe COVID-19 occurred only in participants who received the placebo.

How did trauma centers respond to COVID-19? New processes provide care to trauma patients while keeping providers safe

As the COVID-19 pandemic emerged, trauma centers faced unprecedented obstacles to providing care for injured patients. A look at steps taken by trauma centers in response to COVID-19 is provided by a survey in the January/February Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ).

Higher red cell transfusion threshold offers no advantage for treating preterm infants

Very low birthweight infants often need blood transfusions to survive. A National Institutes of Health-funded study suggests that providing a higher threshold of red cells within accepted limits offers no advantage in survival or reduction in neurological impairment over a lower threshold. The research was conducted by Haresh Kirpalani, B.M., of the University of Pennsylvania, Philadelphia, and colleagues and was funded by the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute, and National Center for Advancing Translational Sciences. The study appears in The New England Journal of Medicine.